BRIEF published on 02/10/2026 at 07:35, 4 months 8 days ago GenSight Biologics Begins REVISE Study for GS010 Therapy GenSight Biologics LHON REVISE Study GS010 Therapy 15-20 National Hospital
PRESS RELEASE published on 02/10/2026 at 07:30, 4 months 8 days ago Inside Information / Other news releases 15-20 National Hospital and GenSight Biologics treat first patient in GS010/LUMEVOQ® REVISE Study, for Leber Hereditary Optic Neuropathy. Clinical study supported by ANSM and aiming to enroll 14 patients in France GenSight Biologics LHON GS010/LUMEVOQ REVISE Study 15-20 National Hospital
BRIEF published on 01/29/2026 at 00:26, 4 months 20 days ago GenSight Biologics Reports EGM Results Shareholders Capital Increase Extraordinary General Meeting GenSight Biologics Financial Authorizations
PRESS RELEASE published on 01/29/2026 at 00:21, 4 months 20 days ago Inside Information / Other news releases GenSight Biologics announces successful Extraordinary General Meeting approving financial authorizations renewal and clarifying rejection of 8th resolution, enhancing company's strategic flexibility Strategy Extraordinary General Meeting GenSight Biologics Gene Therapies Financial Authorizations
BRIEF published on 12/29/2025 at 08:05, 5 months 20 days ago GenSight Biologics Completes €2.9 Million Fundraising Shareholders Fundraising Gene Therapy Retinal Diseases Compassionate Use
PRESS RELEASE published on 12/29/2025 at 08:00, 5 months 20 days ago Inside Information / Other news releases GenSight Biologics successfully raises nearly €2.9 million to fund gene therapies for retinal neurodegenerative diseases, plans to use proceeds for development and operational needs through 2026 Fundraising Proceeds GenSight Biologics Gene Therapies Retinal Diseases
BRIEF published on 12/22/2025 at 07:05, 5 months 27 days ago GenSight Biologics Receives Compassionate Use Authorization for GS010/LUMEVOQ® in France Gene Therapy Rare Diseases Compassionate Use LHON Treatment ANSM Approval
BRIEF published on 12/22/2025 at 07:05, 5 months 27 days ago Issuance of a compassionate access authorization for GS010/LUMEVOQ® Gene Therapy GenSight Biologics NOHL ANSM Compassionate Access
PRESS RELEASE published on 12/22/2025 at 07:00, 5 months 27 days ago Inside Information / Other news releases GenSight Biologics receives Compassionate Use Authorization in France for GS010/LUMEVOQ® gene therapy indicated for ND4-LHON treatment France GenSight Biologics GS010/LUMEVOQ® Compassionate Use Authorization ND4-LHON
BRIEF published on 11/13/2025 at 18:02, 7 months 4 days ago Heights Capital Management crosses thresholds Convertible Bonds Crossing Thresholds Shares And Voting Rights GenSight Biologics Heights Capital
Published on 06/18/2026 at 00:00, 9 hours 46 minutes ago LIR Life Sciences Completes Comparative Animal Study Showing Successful Protamine-Enhanced Permeation Transport of Both Semaglutide and Tirzepatide
Published on 06/17/2026 at 23:30, 10 hours 16 minutes ago Polaris Renewable Energy Announces Postponement of Annual Meeting of Shareholders
Published on 06/17/2026 at 22:50, 10 hours 56 minutes ago International Battery Metals Ltd. Reports Fourth Quarter and Full Year Fiscal 2026 Financial Results
Published on 06/17/2026 at 22:30, 11 hours 16 minutes ago Innodata Appoints Jayant Chauhan as Chief Financial Officer
Published on 06/17/2026 at 16:55, 16 hours 51 minutes ago Snipp Interactive Named a Representative Vendor in the Gartner(R) 2026 Market Guide for Loyalty Program Vendors
Published on 06/18/2026 at 09:30, 16 minutes ago AATec to Present Data from Lead Candidate ATL-105 at World Bronchiectasis Conference 2026
Published on 06/18/2026 at 09:10, 36 minutes ago Lenzing Group highlights scalable, bio-based nonwovens solutions at leading global industry fairs
Published on 06/18/2026 at 09:05, 40 minutes ago Norwegian Water and Energy Authority selects ICEYE to deliver nationwide satellite monitoring capability
Published on 06/18/2026 at 09:00, 45 minutes ago Original-Research: Limes Schlosskliniken AG (von NuWays AG): BUY
Published on 06/18/2026 at 09:00, 45 minutes ago Original-Research: Flughafen Wien AG (von NuWays AG): BUY
Published on 06/18/2026 at 09:06, 39 minutes ago Eiffage, member of the NSORe joint venture, wins the contract for a converter station for the NSC2 offshore grid connection project in Germany
Published on 06/18/2026 at 08:30, 1 hour 16 minutes ago OPmobility wins first awards with Chinese automaker Leapmotor outside of China
Published on 06/18/2026 at 07:00, 2 hours 46 minutes ago bioMérieux introduces Salmonella testing kit on GENE-UP® TYPER to support root cause analysis in the food industry
Published on 06/17/2026 at 17:40, 16 hours 6 minutes ago Report on share repurchases from 10 to 16 June 2026
Published on 06/17/2026 at 08:45, 1 day 1 hour ago Air Liquide is awarded its largest-ever contract in Spain to care for 90,000 patients living with respiratory conditions at home
